|
1
|
Gomaa AI, Khan SA, Toledano MB, Waked I
and Taylor-Robinson SD: Hepatocellular carcinoma: Epidemiology,
risk factors and pathogenesis. World J Gastroenterol. 14:4300–4308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han ZG: Functional genomic studies:
Insights into the pathogenesis of liver cancer. Annu Rev Genomics
Hum Genet. 13:171–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kannan M, Jayamohan S, Moorthy RK,
Chabattula SC, Ganeshan M and Arockiam AJV: AEG-1/miR-221 axis
cooperatively regulates the progression of hepatocellular carcinoma
by targeting PTEN/PI3K/AKT signaling pathway. Int J Mol Sci.
20:55262019. View Article : Google Scholar
|
|
5
|
Feitelson MA, Arzumanyan A, Kulathinal RJ,
Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML,
Nawroth R, Sanchez-Garcia I, et al: Sustained proliferation in
cancer: Mechanisms and novel therapeutic targets. Semin Cancer
Biol. 35 (Suppl):S25–S54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christen B, Beck CW, Lombardo A and Slack
JM: Regeneration-specific expression pattern of three posterior Hox
genes. Dev Dyn. 226:349–355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Bessa Garcia SA, Araujo M, Pereira T,
Mouta J and Freitas R: HOX genes function in breast cancer
development. Biochim Biophys Acta Rev Cancer. 1873:1883582020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adato O, Orenstein Y, Kopolovic J,
Juven-Gershon T and Unger R: Quantitative analysis of differential
expression of HOX genes in multiple cancers. Cancers (Basel).
12:15722020. View Article : Google Scholar
|
|
9
|
Anbazhagan R and Raman V: Homeobox genes:
Molecular link between congenital anomalies and cancer. Eur J
Cancer. 33:635–637. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Argiropoulos B and Humphries RK: Hox genes
in hematopoiesis and leukemogenesis. Oncogene. 26:6766–6776. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li B, Huang Q and Wei GH: The role of HOX
transcription factors in cancer predisposition and progression.
Cancers (Basel). 11:5282019. View Article : Google Scholar
|
|
12
|
Guan Y, He Y, Lv S, Hou X, Li L and Song
J: Overexpression of HOXC10 promotes glioblastoma cell progression
to a poor prognosis via the PI3K/AKT signalling pathway. J Drug
Target. 27:60–66. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang XL, Ding BX, Hua Y, Chen H, Wu T,
Chen ZQ and Yuan CH: HOXC10 promotes the metastasis of human lung
adenocarcinoma and indicates poor survival outcome. Front Physiol.
8:5572017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sadik H, Korangath P, Nguyen NK, Gyorffy
B, Kumar R, Hedayati M, Teo WW, Park S, Panday H, Munoz TG, et al:
HOXC10 expression supports the development of chemotherapy
resistance by fine tuning DNA repair in breast cancer cells. Cancer
Res. 76:4443–4456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pathiraja TN, Nayak SR, Xi Y, Jiang S,
Garee JP, Edwards DP, Lee AV, Chen J, Shea MJ, Santen RJ, et al:
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast
cancer. Sci Transl Med. 6:229ra412014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng X, Li T, Liu Z, Shi Y and Peng Y:
HOXC10 up-regulation contributes to human thyroid cancer and
indicates poor survival outcome. Mol Biosyst. 11:2946–2954. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo C, Hou J, Ao S, Deng X and Lyu G:
HOXC10 up-regulation promotes gastric cancer cell proliferation and
metastasis through MAPK pathway. Chin J Cancer Res. 29:572–580.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao S, He L, Zhang Y, Ye L, Lai Y, Huang
L, Wu L, Wu G and Zhu S: HOXC10 promotes gastric cancer cell
invasion and migration via regulation of the NF-κB pathway. Biochem
Biophys Res Commun. 501:628–635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong W, Zhou Q, Liu G, Liu XS and Li XY:
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes
cell invasion and migration in osteosarcoma cell lines. Tumour
Biol. 39:10104283176975662017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie F, Li Y, Wang M, Huang C, Tao D, Zheng
F, Zhang H, Zeng F, Xiao X and Jiang G: Circular RNA BCRC-3
suppresses bladder cancer proliferation through miR-182-5p/p27
axis. Mol Cancer. 17:1442018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y
and Makuuchi M: Staging of hepatocellular carcinoma: Assessment of
the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772
patients in Japan. Ann Surg. 245:909–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cillo C, Schiavo G, Cantile M, Bihl MP,
Sorrentino P, Carafa V, D'Armiento M, Roncalli M, Sansano S,
Vecchione R, et al: The HOX gene network in hepatocellular
carcinoma. Int J Cancer. 129:2577–2587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova
D, Tang Q, Feng B, Jiang L, He J, et al: Wild-type p53 promotes
cancer metabolic switch by inducing PUMA-dependent suppression of
oxidative phosphorylation. Cancer Cell. 35:191–203.e8. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Tang C, Yu T, Zhang R, Zheng H
and Yan W: MicroRNAs control mRNA fate by compartmentalization
based on 3′ UTR length in male germ cells. Genome Biol. 18:1052017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peluso I, Yarla NS, Ambra R, Pastore G and
Perry G: MAPK signalling pathway in cancers: Olive products as
cancer preventive and therapeutic agents. Semin Cancer Biol.
56:185–195. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ki MR, Lee HR, Goo MJ, Hong IH, Do SH,
Jeong DH, Yang HJ, Yuan DW, Park JK and Jeong KS: Differential
regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis
of gastric epithelial cells. Am J Physiol Gastrointest Liver
Physiol. 294:G635–G647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arch Toxicol. 89:867–882.
2015. View Article : Google Scholar : PubMed/NCBI
|
